4
Changes in Ownership
SUTRO BIOPHARMA, INC. Filed Acc 0001415889-25-023084
Chief Business Officer gave up 8,944 shares (to pay taxes)
- Chief Business Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Leyman Barbara Chief Business Officer | 2025-07-08 | Option exercise | +25,000 | 25,000 | D | ||
| Leyman Barbara Chief Business Officer | 2025-07-08 | Shares withheld for taxes | −8,944 | $0.78 | $6,976 | 16,056 | D |
| Derivatives | |||||||
| Leyman Barbara Chief Business Officer | 2025-07-08 | Option exercise · Restricted Stock Units (RSUs) | −25,000 | 75,000 | D | ||
Loading xslF345X05/form4-08272025_010822.xml…